These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 19500102)

  • 21. [Severe psoriasis: beyond the skin, what are the risks of not treating the disease?].
    Bessis D
    Ann Dermatol Venereol; 2008 Jul; 135 Suppl 5():S285-9. PubMed ID: 18721666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective.
    Wilson PW
    Am J Med; 2008 Oct; 121(10 Suppl 1):S15-20. PubMed ID: 18926165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term prognosis in patients with psoriasis.
    Gulliver W
    Br J Dermatol; 2008 Aug; 159 Suppl 2():2-9. PubMed ID: 18700909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomics and proteomics: a new approach for assessing thrombotic risk in autoimmune diseases.
    López-Pedrera C; Barbarroja N; Aguirre MA; Torres LA; Velasco F; Cuadrado MJ
    Lupus; 2008 Oct; 17(10):904-15. PubMed ID: 18827055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiovascular manifestations of systemic lupus erythematosus].
    Gómez-León Mandujano A; Amezcua-Guerra LM
    Arch Cardiol Mex; 2008; 78(4):421-30. PubMed ID: 19205552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular events in systemic lupus erythematosus and rheumatoid arthritis : emerging concepts, early diagnosis and management.
    Chogle AR; Chakravarty A
    J Assoc Physicians India; 2007 Jan; 55():32-40. PubMed ID: 17444342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disease modification and cardiovascular risk reduction: two sides of the same coin?
    Hall FC; Dalbeth N
    Rheumatology (Oxford); 2005 Dec; 44(12):1473-82. PubMed ID: 16076883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The heartbreak of psoriasis: a review of cardiovascular risk in patients with psoriasis.
    Benson MM; Frishman WH
    Cardiol Rev; 2015; 23(6):312-6. PubMed ID: 26440534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular risk and psoriasis: the role of biologic therapy.
    Puig L
    Actas Dermosifiliogr; 2012 Dec; 103(10):853-62. PubMed ID: 23157913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study.
    Stamatelopoulos KS; Kitas GD; Papamichael CM; Chryssohoou E; Kyrkou K; Georgiopoulos G; Protogerou A; Panoulas VF; Sandoo A; Tentolouris N; Mavrikakis M; Sfikakis PP
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1702-8. PubMed ID: 19608975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Psoriasis as an independent risk factor for development of coronary artery disease].
    Papo D; Hein R; Ring J
    Dtsch Med Wochenschr; 2010 Sep; 135(36):1749-54. PubMed ID: 20812162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cardiovascular risk in systemic inflammatory diseases].
    Marsico F; Parente A; Paolillo S; Casaretti L; Lo Iudice F; Pirozzi E; Conte S; Iardino E; Gambardella F; Della Ratta GL; Cirillo A; Vitagliano A; Filardi PP
    G Ital Cardiol (Rome); 2013; 14(7-8):517-25. PubMed ID: 23877549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pathogenic role of tissue-resident immune cells in psoriasis.
    Boyman O; Conrad C; Tonel G; Gilliet M; Nestle FO
    Trends Immunol; 2007 Feb; 28(2):51-7. PubMed ID: 17197238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cardiovascular manifestations of rheumatic diseases.
    Goodson NJ; Solomon DH
    Curr Opin Rheumatol; 2006 Mar; 18(2):135-40. PubMed ID: 16462518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psoriasis: the visible killer.
    Torres T; Bettencourt N
    Rev Port Cardiol; 2014 Feb; 33(2):95-9. PubMed ID: 24525359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiovascular risk in autoimmune and inflammatory disorders].
    Peeters MA; Chizzolini C
    Rev Med Suisse; 2011 Apr; 7(291):867-71. PubMed ID: 21598728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psoriasis, inflammation, and vascular risk: a problem more than skin deep?
    Ridker PM
    Eur Heart J; 2010 Apr; 31(8):902-4. PubMed ID: 20215124
    [No Abstract]   [Full Text] [Related]  

  • 38. Psoriasis and vascular disease: an unsolved mystery.
    Shelling ML; Federman DG; Prodanovich S; Kirsner RS
    Am J Med; 2008 May; 121(5):360-5. PubMed ID: 18456026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular risk in rheumatoid arthritis.
    Nurmohamed MT
    Autoimmun Rev; 2009 Jul; 8(8):663-7. PubMed ID: 19393192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrovascular disease and atherosclerosis in SSc.
    Hettema ME; Bootsma H; Kallenberg CG
    Rheumatology (Oxford); 2008 May; 47(5):578-83. PubMed ID: 18321944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.